สหภาพยุโรป - เดนมาร์ก - EMA (European Medicines Agency)

sanofi belgium - alemtuzumab - multipel sclerose - selektive immunosuppressiva - lemtrada er indiceret til voksne patienter med recidiverende remitterende multipel sklerose (rrms) med aktiv sygdom defineret ved kliniske eller billeddannende egenskaber.

สหภาพยุโรป - เดนมาร์ก - EMA (European Medicines Agency)

abbvie deutschland gmbh co. kg - ombitasvir, paritaprevir, ritonavir - hepatitis c kronisk - antivirale midler til systemisk anvendelse - viekirax er indiceret i kombination med andre lægemidler til behandling af kronisk hepatitis c (chc) hos voksne. for at hepatitis c virus (hcv) genotype specifikke aktivitet.

เดนมาร์ก - เดนมาร์ก - Lægemiddelstyrelsen (Danish Medicines Agency)

orifarm a/s - ethinylestradiol, etonogestrel - vaginalindlæg - 120+15 mikg/24 timer

เดนมาร์ก - เดนมาร์ก - Lægemiddelstyrelsen (Danish Medicines Agency)

paranova danmark a/s - ethinylestradiol, etonogestrel - vaginalindlæg - 120+15 mikg/24 timer

เดนมาร์ก - เดนมาร์ก - Lægemiddelstyrelsen (Danish Medicines Agency)

b. braun melsungen - ropivacainhydrochloridmonohydrat - injektionsvæske, opløsning - 10 mg/ml

สหภาพยุโรป - เดนมาร์ก - EMA (European Medicines Agency)

kite pharma eu b.v. - axicabtagene ciloleucel - lymphoma, follicular; lymphoma, large b-cell, diffuse - antineoplastiske midler - yescarta is indicated for the treatment of adult patients with diffuse large b cell lymphoma (dlbcl) and high-grade b-cell lymphoma (hgbl) that relapses within 12 months from completion of, or is refractory to, first-line chemoimmunotherapy. yescarta is indicated for the treatment of adult patients with relapsed or refractory (r/r) dlbcl and primary mediastinal large b cell lymphoma (pmbcl), after two or more lines of systemic therapy. yescarta is indicated for the treatment of adult patients with r/r follicular lymphoma (fl) after three or more lines of systemic therapy.

สหภาพยุโรป - เดนมาร์ก - EMA (European Medicines Agency)

pfizer europe ma eeig - nirmatrelvir, ritonavir - covid-19 virus infection - paxlovid is indicated for the treatment of coronavirus disease 2019 (covid-19) in adults who do not require supplemental oxygen and who are at increased risk for progressing to severe covid 19.

สหภาพยุโรป - เดนมาร์ก - EMA (European Medicines Agency)

horizon therapeutics ireland dac - inebilizumab - neuromyelitis optica - immunosuppressiva - uplizna is indicated as monotherapy for the treatment of adult patients with neuromyelitis optica spectrum disorders (nmosd) who are anti-aquaporin 4 immunoglobulin g (aqp4-igg) seropositive (see section 5.

สหภาพยุโรป - เดนมาร์ก - EMA (European Medicines Agency)

gilead sciences ireland uc - elvitegravir, cobicistat, emtricitabine, tenofovir alafenamide - hiv infektioner - antivirale midler til systemisk anvendelse - genvoya er indiceret til behandling af voksne og unge (alderen 12 år og ældre med kroppen vægt mindst 35 kg) inficeret med human immundefekt virus 1 (hiv 1) uden nogen kendt mutationer i forbindelse med modstand mod integrase inhibitor klasse, emtricitabine eller tenofovir.

เดนมาร์ก - เดนมาร์ก - Lægemiddelstyrelsen (Danish Medicines Agency)

b. braun melsungen - ropivacainhydrochloridmonohydrat - injektionsvæske, opløsning - 5 mg/ml